Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 24
Jurors Add $9 Million Punitive Award to Vioxx Plaintiff's $4.5 Million Verdict
Arthritis Drugs - Issue: 23
Vioxx Distributors Maintain No Liability for Failure to Warn
Merck: Foreign Vioxx Class Actions Belong in Home Jurisdictions, Not MDL
N.J. Jury Enters Split Verdict in First 'Long-Term Use' Vioxx Trial
PSC Seeks Remand Procedure to Improve Vioxx MDL Trial Efficiency
Plaintiffs Say Vioxx Distributors Legally Liable for Failure to Warn
Court Affirms Vioxx Third-Party Payor Class Certification
Arthritis Drugs - Issue: 22
Arthritis Drugs in the Medical Literature This Month - March 2006
